Home › Funds › Penn Capital Management Company, LLC › TVTX

Penn Capital Management Company, LLC position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Penn Capital Management Company, LLC reported holding 260,467 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 1.14% of its reported portfolio and ranking #47 among its reported holdings. Penn Capital Management Company, LLC has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)260.47K sh
Reported value held$15.35M
Portfolio Weight1.14%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Penn Capital Management Company, LLC's TVTX position evolved

Penn Capital Management Company, LLC first disclosed a stake in TVTX in Q1 2025 at 21,094 shares (US$378K). The position peaked in Q3 2026 at 260,467 shares, worth US$15.4M. Across 7 filings, Penn Capital Management Company, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 260,467 shares valued at US$15.4M — an increase of 245,499 shares quarter over quarter.. Notable position changes include a 40% increase in Q3 2025 (shares rose 60% over the following quarter), a 56% trim in Q4 2025 (shares fell 22% over the following quarter), a 1640% increase in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 21.09K $378.00K New
Q2 2025 19.32K $286.00K Reduce
Q3 2025 27.00K $645.40K Add
Q4 2025 11.87K $453.44K Reduce
Q1 2026 12.68K $376.60K Add
Q2 2026 14.97K $850.33K Add
Q3 2026 260.47K $15.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Penn Capital Management Company, LLC held TVTX?

Penn Capital Management Company, LLC has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Penn Capital Management Company, LLC's current position in TVTX?

As of Q3 2026, Penn Capital Management Company, LLC holds 260.47K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $15.35M, representing 1.14% of its reported portfolio and ranking #47.

Has Penn Capital Management Company, LLC been buying or selling TVTX?

In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC increased its position in TVTX. The position peaked in Q3 2026 at 260.47K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.